Table 1 Demographic and clinical characteristics
|  | All patients n = 32 (%) | Thrombosis n = 9 (%) | Non-thrombotic n = 23 (%) | P value |
|---|---|---|---|---|
 Sex (female/male) | 21/11 | 4/5 | 17/6 | 0.11 |
 Age (years) | 11.7 (1–15) | 12.2 (1–15) | 11.5 (6–15) | 0.93 |
 Evolution time (weeks) | 16 (1–108) | 7.5 (1–28) | 19 (1–108) | 0.21 |
 Hematologic | 29 (90%) | 7 (78%) | 22 (96%) |  |
 Thrombocytopenia | 22 (67%) | 7 (78%) | 15 (65%) | 0.49 |
 AIHA | 13 (41%) | 2 (22%) | 11 (48%) | 0.18 |
 LAHP | 2 (6%) | 0 | 2 (9%) | 0.36 |
 Dermatologic | 23 (72%) | 7 (78%) | 16 (70%) |  |
 Livedo reticularis | 20 (63%) | 7 (78%) | 13 (57%) | 0.26 |
 Raynaud's phenomenon | 8 (25%) | 2 (22%) | 6 (26%) | 0.82 |
 Skin ulcers | 2 (6%) | 0 | 2 (9%) | 0.36 |
 Neurologic | 5 (16%) | 1 (11%) | 4 (17%) |  |
 Migraine | 3 (9%) | 1 (11%) | 2 (9%) | 0.83 |
 Cognitive impairment | 3 (9%) | 1 (11%) | 2 (9%) | 0.83 |
 Epilepsy | 1 (3%) | 1 (11%) | 0 | 0.10 |
 Chorea | 1 (3%) | 0 | 1 (4%) | 0.52 |
 Renal | 4 (13%) | 3 (33%) | 1 (4%) |  |
 Nephrotic sÃndrome | 1 (3%) | 1 (11%) | 0 | 0.10 |
 Nephritic syndrome | 3 (9%) | 2 (22%) | 1 (4%) | 0.11 |
Clinical profile | ||||
 T | 1 (3%) | 1 (11%) | 0 |  |
 H | 6 (19%) | 0 | 6 (26%) |  |
 R | 1 (3%) | 1 (11%) | 0 |  |
 C | 1 (3%) | 0 | 1 (4%) |  |
 H + C | 16 (50%) | 5 (55%) | 11 (48%) |  |
 H + N | 1 (3%) | 0 | 1 (4%) |  |
 H + C + R | 2 (6%) | 1 (11%) | 1 (4%) |  |
 H + C + N | 3 (9%) | 0 | 3 (13%) |  |
 H + C + N + R | 1 (3%) | 1 (11%) | 0 |  |